Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
[Recurring neuromyelitis without optic neuritis: a case report].
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Scrub typhus with longitudinally extensive transverse myelitis.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
HMGB1 in Development and Diseases of the Central Nervous System.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Functional plasticity in MS: Friend or foe?
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Uveitis as a prognostic factor in multiple sclerosis.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.

Pages